US Patent 7906507 Oxadiazoanthracene compounds for the treatment of diabetes
Patent 7906507 was granted and assigned to TransTech Pharma on March, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7906507 Oxadiazoanthracene compounds for the treatment of diabetes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
